Mibefradil: A Selective T-Type Calcium Antagonist

This publication has 29 references indexed in Scilit:

• A randomised, double-blind trial comparing mibefradil and amlodipine: two long-acting calcium antagonists with similar efficacy but different tolerability profiles
  Journal of Human Hypertension, 1997
• Protein Families That Mediate Ca2+ Signaling in the Cardiovascular System
  The American Journal of Cardiology, 1996
• Pharmacologic and Therapeutic Differences Among Calcium Channel Antagonists: Profile of Mibefradil, a New Calcium Antagonist
  The American Journal of Cardiology, 1996
• Calcium channel diversity in the cardiovascular system
  Journal of the American College of Cardiology, 1996
• Effects of a new calcium antagonist, mibefradil (Ro 40–5967), on silent ischemia in patients with stable chronic angina pectoris: A multicenter placebo-controlled study
  Journal of the American College of Cardiology, 1996
• Effects of the new calcium antagonist mibefradil (Ro 40-5967) on exercise duration in patients with chronic stable angina pectoris: A multicenter, placebo-controlled study
  American Heart Journal, 1995
• Mibefradil Prevents Neointima Formation After Vascular Injury in Rats
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1995
• Effects of calcium channel blockade on the aortic intima in spontaneously hypertensive rats.
  Hypertension, 1993
• The structurally novel Ca2+ channel blocker Ro 40-5967, which binds to the [3H] desmethoxyverapamil receptor, is devoid of the negative inotropic effects of verapamil in normal and failing rat hearts
  Cardiovascular Drugs and Therapy, 1990
• Effects of Ro 40-5967, a Novel Calcium Antagonist, on Myocardial Function During Ischemia Induced by Lowering Coronary Perfusion Pressure in Dogs: Comparison with Verapamil
  Journal of Cardiovascular Pharmacology, 1989